Developing Complex, Translatable & Physiologically-Relevant Cellular Models in Vitro
Conference Co-Chairs: Stefan Przyborski, Professor of Cell Technology, Durham University & Philip Hewitt, Global Head of Early Investigative Toxicology, Merck
3D Cell Culture is gaining momentum in the pharmaceutical industry on account of the advantages such models pose for in drug discovery, from improved clinical translation & predictivity, to patient safety & sustainability
